Valproic Acid in the Treatment of Nonepileptic Myoclonus
Arch Neurol 39:448-449, Sotaniemi,K.,et al, 1982
Postanoxic Action Myoclonus (Lance-Adams Syndrome) Responding to Valproate
Arch Neurol 36:44-45, Rollinson,R.D.,et al, 1979
Post-anoxic Action Myoclonus:Improvement with Valproic Acid
NEJM 299:313, Fah,S., 1978
The SANAD II Study of the Effectiveness and Cost-Effectiveness of Valproate Versus Levetiracetam for Newly Diagnosed Generalised and Unclassifiable Epilepsy: An Open-Label, Non-Inferiority, Multicentre, Phase 4, Randomised Controlled Trial
Lancet 397:1375-1386, Marson, A.,et al, 2021
Antiepileptic Drug Treatment Patterns in Women of Childbearing Age with Epilepsy
JAMA Neurol 76:783-790, Kim, H.,et al, 2019
Risk of 23 Specific Malformations Associated with Prenatal Exposure to 10 Antiepileptic Drugs
Neurol 93:e167-e180, Blotiere, P.O.,et al, 2019
Declining Malformation Rates with Changed Antiepileptic Drug Prescribing, An Observational Study
Neurol 93:e831-e840, Tomson,T.,et al, 2019
A 22-year-old Man Presenting with Headache and Right Leg Jerks
Neurol 91:891-895, Schupper, A.J.,et al, 2018
Maternal Use of antiepileptic Agents During Pregnancy and Major Congenital Malformations in Children
JAMA 318:1700-1701, Bromley, R.L.,et al, 2017
Clinicopathologic Conference, Copper Deficiency Myelopathy
NEJM 377:1977-1984, Case 35-2017, 2017
Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism
JAMA 309:1696-1703, Christensen, J.,et al, 2013
Child Development Following In Utero Exposure: Levetiracetam vs Sodium Valproate
Neurol 76:383-389, Shallcross,R.,et al, 2011
Valproic Acid Monotherapy in Pregnancy and Major Congenital Malformations
NEJM 362:2185-2193, Jentink,J., et al, 2010
Cognitive Function at 3 Years of Age After Fetal Exposure to Antiepileptic Drugs
NEJM 360:1597-1605,1667, Meador,K.J.,et al, 2009
Malformation Risks of Antiepileptic Drugs in Pregnancy: A Prospective Study from the UK Epilepsy and Pregnancy Register
JNNP 77:193-198,145, Morrow,J.,et al, 2006
In Utero Antiepileptic Drug Exposure: Fetal Death and Malformations
Neurol 67:407-412, Meador,K.J.,et al, 2006
Teratogenicity of Antiepileptic Drugs
BMJ 333:615-616, Breen,D.P. &Davenport,R.J., 2006
Increased Rate of Major Malformations in Offspring Exposed to Valproate Durng Pregnancy
Neurol 64:961-965, 938, Wyszynski,D.F., et al, 2005
Intravenous Valproic Acid for Myoclonic Status Epilepticus
Neurol 54:1201, Sheth,R.D. & Gidal,B.E., 2000
Protein C Deficiency Related to Valproic Acid Therapy: A Possible Association with Childhood Stroke
J Pediatr 137:714-718, Gruppo,R.,et al, 2000
Antiepileptic Drugs
NEJM 334:168-175, Brodie,M.J.&Dichter,M.A., 1996
Cortical Myoclonus in Huntington's Disease
Movement Disorders 9:633-641, Thompson,P.D.,et al, 1994
Juvenile Myoclonic Epilepsy
Arch Neurol 50:594-598, Grunewald,R.A.&Panayiotopoulos,C.P., 1993
Juvenile Myoclonic Epilepsy, Underdiagnosed and Treatment May Have to be Life Long
BMJ 305:4-5, Timmings,P.L.&Richens,A., 1992
Delayed Diagnosis of Juvenile Myoclonic Epilepsy
JNNP 55:497-499, Grunewald,R.A.,et al, 1992
Myoclonus in Adult Huntington's Disease
Ann Neurol 29:213-215, Vogel,C.M.,et al, 1991
Epileptic Seizures and Syndromes
Lancet 336:161-163, Gram,L., 1990
Epilepsy in Women of Childbearing Age, If Anticonvulsants Cannot be Avoided Use Carbamazepine
BMJ 298:581, Saunders,M., 1989
Gastritis with Valproate Therapy
Arch Neurol 45:903-905, Marks,W.A.,et al, 1988
Treatment of Ocular Myoclonus with Valproic Acid
Ann Neurol 17:103-104, Lefkowitz,D.,et al, 1985
Hyperekplexia:A Syndrome of Pathological Startle Responses
Ann Neurol 15:36-41, Saenz-Lope,E.,et al, 1984
Valproate & Clonazepam in the Treatment of Severe Progressive Myoclonus Epilepsy
Arch Neurol 39:236-238, Iivanainen,M.,et al, 1982
Valproic Acid, Treatment of Myoclonus in Dyssynergia Cerebellaris Myoclonica
Arch Neurol 39:527-528, Sommerville,E.R.,et al, 1982
Valproic Acid
NEJM 302:661-666, Brown,T.R., 1980
Sodium Valproate & Clonazepam in the Treatment of Intractable Epilepsy
Arch Neurol 34:14, Lance,W.,et al, 1977